Dog var den afstand, patienterne kunne gå på 6 minutter, ens i de to grupper.
In patients with class II disease, Tracleer caused the resistance of the blood vessels to decrease by 23% compared with placebo after six months of treatment, but the distance the patients could walk over six minutes was similar in the two groups.